Phospho-IκBα (Ser32/36) Antibody [F24N7]

N° de catalogue F0197

Imprimer

Description biologique

Spécificité

Phospho-IκBα (Ser32/36) Antibody [F24N7] détecte les niveaux endogènes d'IκBα uniquement lorsqu'il est phosphorylé en Ser32/36.

Contexte Le complexe IκB kinase (IKK) sert de centre de signalisation principal pour l'activation de la voie NF-κB. Ce complexe est composé de deux sous-unités catalytiques, IKKα et IKKβ, qui sont des sérine/thréonine kinases, et d'une sous-unité régulatrice connue sous le nom de NEMO (NF-κB essential modulator), également appelée IKKγ. Le complexe IKK intègre un large éventail de signaux en amont qui activent NF-κB, conduisant à la phosphorylation des protéines IκB, des sous-unités NF-κB et d'autres cibles cellulaires. Dans les cellules non stimulées, les facteurs de transcription NF-κB sont maintenus dans un état inactif dans le cytoplasme par liaison à des protéines IκB inhibitrices, telles que IκBα, IκBβ et IκBε, ou aux protéines précurseurs p100 et p105. Ces protéines inhibitrices empêchent NF-κB d'entrer dans le noyau et d'initier la transcription génique. Lors de la stimulation, les protéines IκB sont phosphorylées sur des résidus sérine spécifiques — en particulier Ser32 et Ser36 dans le cas d'IκBα — par le complexe IKK activé. Cette phosphorylation marque IκB pour la reconnaissance par le complexe SCFβTrCP E3 ubiquitine ligase, conduisant à son ubiquitination et à sa dégradation ultérieure via le protéasome. La dégradation d'IκB libère les dimères NF-κB, qui transloquent ensuite vers le noyau où ils dirigent la transcription des gènes cibles. Une grande variété de signaux externes, y compris les cytokines inflammatoires, les facteurs de croissance et les chimiokines, peut déclencher cette cascade, entraînant finalement la phosphorylation d'IκBα et l'activation de l'expression génique dépendante de NF-κB.

Informations dutilisation

Application WB Dilution
WB
1:1000
Réactivité Human, Mouse, Rat, Monkey
Source Mouse Monoclonal Antibody MW 40 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 150s is recommended)

Références

  • https://pubmed.ncbi.nlm.nih.gov/24375677/
  • https://pubmed.ncbi.nlm.nih.gov/7878466/

Données dapplication

WB

Validé par Selleck

  • F0197-wb
    Lane 1: Hela, Lane 2: Hela (IFNa, 20 ng/mL, 5 min), Lane 3: 3T3, Lane 4: 3T3 (IFNa, 20 ng/mL, 5 min)